The U.S. Blood System: Under Pressure
Dr. Menitove discusses obstacles and pressure on U.S. blood centers and the U.S. blood supply.
Ground-Breaking Trial Shows Aspirin Is As Effective As Rivaroxaban Following Hip and Knee Arthroplasty
Dr. Linkins looks at evidence that demonstrates that aspirin is as effective as oral anticoagulant rivaroxaban post hip and knee arthroplasty in a significant subset of pat
Dr. Moss discusses the CLARITY study, which looks at the combination of therapies venetoclax and ibrutinib to treat relapsed/refractory chronic lymphocytic leukemia.
Dr. Moss reviews the pathogenesis and potential eradication of favism.
Dr. Moss covers several trials that have solidified the use of venetoclax as the new backbone within a range of combination therapies that should achieve extremely deep therapeutic responses in CLL.
Dr. Moss evaluates a case that requires CAR-T cell therapy and discusses practical issues hematologists should be aware of during introduction of this treatment.
Dr. Moss covers a radical revision of the classification of dendritic cells and monocytes.
Dr. Moss reviews the first trial to show that an immunotherapeutic agent improves survival over chemotherapy in relapsed or refractory ALL patients.
Dr. Moss reviews the first phase III randomized study in systemic mastocytosis (SM), focusing attention on the unmet need of patients with indolent forms of SM who have refractory mediator symptoms despite the use of conventional medications.
Dr. Moss covers updates in the management of the most common subtype of leukemia, CLL. He focuses on the value of BTK inhibition.
Dr. Moss covers a study that compares the PD-1 inhibitor pembrolizumab with brentuximab vedotin in subjects with relapsed or refractory classical HL.
Dr. Moss looks at updates regarding the genomic classification of and treatment approaches to acute myeloid leukemia.
May-June 2018Volume 15, Issue 3
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology